Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Emanuele Valeriani Marcello Di Nisio Nicoletta RivaOmri CohenEttore PorrecaMarco SenzoloAndrea De GottardiMarta MagazJuan-Carlos Garcia-PaganWalter Ageno

Published in: Thrombosis and haemostasis (2021)

Anticoagulant therapy seems to improve vein recanalization and to reduce SVT progression, major bleeding, and overall mortality in cirrhotic patients with SVT. The incidence of recurrent VTE during anticoagulation remains substantial.

Keyphrases

venous thromboembolism
atrial fibrillation
risk factors
pulmonary embolism
cardiovascular events
stem cells
type diabetes
combination therapy
replacement therapy
mesenchymal stem cells
cell therapy